ScreenerHero

SHPH Shuttle Pharmaceuticals Holdings, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · shuttlepharma.com
4.710USD+16.01%Mkt Cap: 22.44M $P/E: —

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular dis…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap22.44M USD
Enterprise Value19.45M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-11.72M USD
Revenue/Share—
Last Price4.710 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.01
EV/Revenue—
P/S—
P/B0.67
EPS (TTM)-17.12
EPS (Forward)—
52W Range
2.5764% of range55.90
52W High55.90 USD
52W Low2.576 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-519.94%
ROA-111.89%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.48M USD
CapEx (TTM)3.06M USD
FCF Margin—
FCF Yield-12.74%
Net Debt104.92K USD
Net Debt/EBITDA-0.01
Balance Sheet
Debt/Equity0.10
Current Ratio0.11
Quick Ratio0.03
Book Value/Sh6.03 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 11, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.76M
Float4.76M
Insiders0.84%
Institutions1.93%
Short Interest
Short Ratio0.4d
Short % Float2.15%
Short % Out.2.14%
Shares Short21.98K
Short (prev mo.)52.92K
Technical
SMA 503.710 (+27.0%)
SMA 2008.253 (-42.9%)
Beta1.14
S&P 52W Chg16.45%
Avg Vol (30d)36.54K
Avg Vol (10d)31.48K
Technical Indicators
RSI (14)66.1
MACD0.1581
MACD Signal0.0783
MACD Hist.+0.0798
BB Upper4.507 USD
BB Middle3.806 USD
BB Lower3.105 USD
BB Width36.83%
ATR (14)0.3500 USD
Vol Ratio (20d)4.16x